Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
-0.61%
SPX
-0.08%
IXIC
+0.08%
FTSE
-0.56%
N225
0.00%
AXJO
0.00%
Cashu Logo
⌘K
Log In
HomeWatchlistNewsSignals
Stocks
0.00 (0.00%)
0.000
USD
At close at --,----
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

Overview

Loading chart...

Key Stats

Market Cap
1.14B
Dividend Yield
0.00%
P/E Ratio
-5.72
EPS
-4.93
Revenue
27.12M
Avg. Volume
9.94M

Recently from Cashu

publisher logo
Cashu

uniQure N.V. Positioned for Growth Amid FDA Leadership Changes and Regulatory Opportunities

1 day ago
publisher logo
Cashu

Regulatory Challenges and Uncertainty Impacting Gene Therapy Development for uniQure N.V.

3 days ago
publisher logo
Cashu

uniQure N.V. Faces Intensified Regulatory Scrutiny and Lawsuit Amidst FDA Trial Demands

4 days ago

About

What does QURE do?
uniQure NV, headquartered in Amsterdam, specializes in gene therapies and employs 480 staff, focusing on one-time treatments for genetic diseases. Their lead candidates include AMT-061 for hemophilia B and AMT-130 for Huntington's disease.
Sector
💻 Health Care
IPO
CEO
Employees
209
Headquarters
Netherlands
Website
http://www.uniqure.com
Join our newsletter to keep up to date with us!
Stocks
Health Care
qure
uniQure N.V.
NASDAQ: QURE
-0.69 (-3.78%)
17.57
USD
At close at Mar 11, 20:40 UTC
Summary
News
Signals
Benchmarks
Financials